hydrocortisone (psm)
psm healthcare ltd trading as api consumer brands - hydrocortisone 1%{relative} (synthesis uses no animal materials); - topical cream - 1 % - active: hydrocortisone 1%{relative} (synthesis uses no animal materials) excipient: cetomacrogol 1000 cetostearyl alcohol chlorocresol liquid paraffin purified water white soft paraffin
hydrocortisone (psm)
psm healthcare ltd trading as api consumer brands - hydrocortisone 1%{relative} - topical cream - 1 % - active: hydrocortisone 1%{relative}
hydrocortisone 0.5% (psm)
psm healthcare ltd trading as api consumer brands - hydrocortisone 0.5%{relative} (synthesis uses no animal materials) - topical cream - 0.5 % - active: hydrocortisone 0.5%{relative} (synthesis uses no animal materials) excipient: cetomacrogol 1000 cetostearyl alcohol chlorocresol liquid paraffin purified water white soft paraffin
quinine sulphate (psm)
psm healthcare ltd trading as api consumer brands - quinine sulfate dihydrate 300mg - film coated tablet - 300 mg - active: quinine sulfate dihydrate 300mg
venlafaxine xr
psm healthcare ltd trading as api consumer brands - venlafaxine hydrochloride 169.738mg equivalent to venlafaxine 150 mg - modified release capsule - 150 mg - active: venlafaxine hydrochloride 169.738mg equivalent to venlafaxine 150 mg excipient: acryl-eze white 93018508 ethylcellulose gelatin capsule - opaque brown - 0300/2006 hypromellose isopropyl alcohol methylene chloride microcrystalline cellulose povidone purified talc tekprint ink white sb-1018 triethyl citrate - venlafaxine hydrochloride modified release capsules is indicated for the treatment of: · major depression · generalised anxiety disorder · social anxiety disorder · panic disorder. venlafaxine hydrochloride modified release capsules is also indicated for the prevention of relapse and recurrence of major depression where appropriate.
venlafaxine xr
psm healthcare ltd trading as api consumer brands - venlafaxine hydrochloride 84.869mg equivalent to venlafaxine 75 mg - modified release capsule - 75 mg - active: venlafaxine hydrochloride 84.869mg equivalent to venlafaxine 75 mg excipient: acryl-eze white 93018508 ethylcellulose gelatin capsule - pink - 0780/2006 isopropyl alcohol methylene chloride microcrystalline cellulose povidone purified talc tekprint red sb-1018 triethyl citrate - venlafaxine hydrochloride modified release capsules is indicated for the treatment of: · major depression · generalised anxiety disorder · social anxiety disorder · panic disorder. venlafaxine hydrochloride modified release capsules is also indicated for the prevention of relapse and recurrence of major depression where appropriate.
benzoic acid
psm healthcare ltd trading as api consumer brands - benzoic acid 5%{relative} - topical solution - 5% w/v - active: benzoic acid 5%{relative}
acriflavine
psm healthcare ltd trading as api consumer brands - acriflavine 0.1%{relative} - topical solution - 0.1% w/v - active: acriflavine 0.1%{relative}
amaranth
psm healthcare ltd trading as api consumer brands - amaranth 10 g; chloroform 200 ml; glycerol 250 ml - solution - 1 % - active: amaranth 10 g chloroform 200 ml glycerol 250 ml
amcal paracetamol (orange flavour)
psm healthcare ltd trading as api consumer brands - paracetamol 4.167%{relative}; ; - oral suspension - 250 mg/5ml - active: paracetamol 4.167%{relative} excipient: citric acid glycerol macrogol stearate 400 orange concentrate firmenich purified water saccharin sodium sodium citrate dihydrate sodium cyclamate sodium methyl hydroxybenzoate sorbitol sunset yellow fcf xanthan gum